梅州哪家医院打胎较好梅州阴道炎影响怀孕么,梅州哪的隆鼻好,梅州打胎的总价格要多少钱,梅州怀孕多久可以做 人流,梅州做微管人流总共多少钱,梅州拉皮去皱价钱,梅州引起霉菌性阴道炎原因

PARIS, Aug. 19 (Xinhua) -- Marine scientists and representatives from the private sector and military establishments would meet at UNESCO at the end of this month to measure noise's impact on marine life, the Paris-based UN scientific branch UNESCO said Friday.The main agenda of the meeting, which is due from Aug. 30 to Sep. 1, was to discuss the program of the International Quiet Ocean Experiment (IQOE)."This decade-long project aims to fill the considerable knowledge gaps in this area, so that management of ocean noise can be more informed and effective," UNESCO said in a statement.The Quiet Ocean Experiments was initiated against the background that human activities on the high seas have increased significantly in recent decades, and resulted in impact upon many marine species relying mainly on sound to communicate.However, some sounds are suspected to alter the behavior of marine animals. For example, several whale species have raised the volume of the squeaks, clicks and moans by which they communicate with each other.The experiment is organized by the Scientific Committee on Oceanic Research (SCOR) and the Partnership for Observation of the Global Oceans (POGO), of which UNESCO's Intergovernmental Oceanographic Commission (IOC) is a member.

BEIJING, Sep. 13 (Xinhuanet) --Experts have called for a national drug-control system after a nationwide deficit of a life-saving drug, which has lasted at least three months.Doctors at a Beijing hospital said some specialized hospitals, which perform hundreds of cardiac operations every month, have been paralyzed by their lack of protamine sulfate, which is commonly administered after heart surgery to reverse the anticoagulant effects of heparin.The earliest report of a shortage was in Hubei province on July 21. This was followed by reports of shortages in Guangdong, Shandong and Liaoning provinces.The Shandong newspaper, Qilu Evening News, quoted a regional sales manager, surnamed Zhuang, as saying the province had been allocated 150 doses of protamine sulfate after Shanghai No 1 Biochemical and Pharmaceutical Co Ltd recently resumed production of the drug."But its monthly use here is usually 10,000 doses," he said.The Ministry of Health has denied it is responsible for supplies of the drug and passed the buck to the State Food and Drug Administration, claiming the latter is responsible for the supervision of medicines.Shen Chen, head of the publicity office of the State Food and Drug Administration, said he was unaware of the shortage, but said the administration is responsible for the quality of medicines, not the supply."Development and reform authorities oversee the medicines' prices, while the industrial and commercial authorities oversee the storage. The food and drug departments only cover the approval and quality of medicines."Industry insiders said one of the reasons for the shortage was the low profit margin, which discourages companies from mass producing the drug."Some companies can't earn enough to recover their costs, therefore it is almost impossible to maintain their enthusiasm for continuing production," said Lu Guoping, secretary-general of the Shanghai Pharmaceutical Trade Association.Lu said the government should issue policies to prevent future shortages of such medicines to avoid possible nationwide public health incidents.Yi Shenghua, a lawyer at Beijing Yingke Law Firm, said the country should have a unified system to guarantee the normal supply of medicines that are widely used and drug manufacturers should fulfill their responsibilities to society, even though there is no law stipulating they should produce specific medicines.He came up with two ways to deal with the problem of companies only producing profitable drugs."The government can order businesses to manufacture a certain amount of cheap medicines. Or it can offer financial assistance to subsidize cheap, but life-saving medicines."

BEIJING, July 1 (Xinhuanet) -- China must adopt a holistic approach to addressing food safety challenges connected to the risk of contracting infectious diseases from contact with animals, the World Health Organization (WHO) has said. Peter Ben Embarek, food safety officer at WHO's China office, said the country faces risks connected to the need to produce more meat, eggs and milk to feed its growing population. He said the increased production will ramp up the risk of people being infected by food-borne diseases because of poor slaughtering oversight and the absence of proper surveillance and inspection systems. About 50 percent of pigs in China are slaughtered outside of formal facilities without the inspection of veterinarians or food safety officers. He said poorly trained producers have little or no awareness of food safety or the risk of animal diseases being passed on to humans. Such an environment could lead to the emergence of a new pandemic of influenza. During the past 60 years, 30 percent of the 335 new infectious diseases worldwide were transmitted through food, he said. Yet in many parts of China, public awareness remains low about such things. Xu Aixiang, a 35-year-old resident of Rizhao city in Shandong province, prefers to buy live poultry at local markets. Like many of her neighbors, she takes the chickens she buys home to slaughter them. "I get fresher chickens that are better quality this way," she said. "When vendors sell slaughtered chickens, the meat is no longer fresh and may have had water injected into it to make it heavier." But Ben Embarek cautioned that such live-animal markets are high-risk places for the exchange of viruses and diseases between animals and humans. He said simple and cost-effective measures can be taken to improve such markets' hygiene standards, such as the installation of separate areas to keep live poultry away from customers as well as improving air flow and waste management. Several UN agencies, including the WHO and the Food and Agriculture Organization, called on China to adopt an integrated approach to preventing emerging epidemic diseases and maintaining ecosystem integrity at an event themed "One Health" that convened on Wednesday in Beijing. At the gathering, representatives from the Ministry of Health, the Ministry of Agriculture and the Chinese Center for Disease Control and Prevention shared experiences from efforts to mitigate the H5N1 and H1N1 influenza outbreaks in China and said they were committed to working together in the future. Su Jingliang, an associate professor of preventive veterinary medicine at China Agricultural University, said his lab had detected the outbreak of a new type of flavivirus in ducks that led to a significant fall in egg production at farms in Beijing as well as in Hebei, Jiangxi and Shandong provinces. The pandemic was brought under control in March. No cases of humans contracting the disease have been reported so far but Su said he was concerned about the possibility of farmers becoming infected through close contact and long exposure to sick ducks. He said precautionary measures should be taken in cooperation with the Ministry of Health and other government agencies and checks should be run on people who are at high risk. Xu Wei contributed to this story.

LOS ANGELES, July 18 (Xinhua) -- The spacecraft Dawn of the National Aeronautics and Space Administration (NASA) has returned the first close-up image of the giant asteroid Vesta after entering its orbit for the first time last week, the Jet Propulsion Laboratory (JPL) announced on Monday.The image taken for navigation purposes shows Vesta in greater detail than ever before, said JPL in Pasadena, California.On July 15, Dawn became the first probe to enter orbit around an object in the main asteroid belt between Mars and Jupiter.When Vesta captured Dawn into its orbit, there were approximately 9,900 miles (about 16,000 kilometers) between the spacecraft and the asteroid.Vesta is 330 miles (about 530 kilometers) in diameter and the second most massive object in the asteroid belt.NASA's Dawn spacecraft obtained this image with its framing camera on July 17, 2011. It was taken from a distance of about 9,500 miles (15,000 kilometers) away from the protoplanet Vesta. Each pixel in the image corresponds to roughly 0.88 miles (1.4 kilometers). Ground- and space-based telescopes have obtained images of Vesta for about two centuries, but they have not been able to see much detail on its surface."We are beginning the study of arguably the oldest extant primordial surface in the solar system," said Dawn principal investigator Christopher Russell from the University of California, Los Angeles, which is responsible for Dawn's mission science. " This region of space has been ignored for far too long. So far, the images received to date reveal a complex surface that seems to have preserved some of the earliest events in Vesta's history, as well as logging the onslaught that Vesta has suffered in the intervening eons."Vesta is thought to be the source of a large number of meteorites that fall to Earth. Vesta and its new NASA neighbor, Dawn, are currently approximately 117 million miles (about 188 million kilometers) away from Earth. The Dawn team will begin gathering science data in August.Observations will provide unprecedented data to help scientists understand the earliest chapter of the solar system and pave the way for future human space missions, according to JPL."Dawn slipped gently into orbit with the same grace it has displayed during its years of ion thrusting through interplanetary space," said Marc Rayman, Dawn chief engineer and mission manager at NASA's JPL. "It is fantastically exciting that we will begin providing humankind its first detailed views of one of the last unexplored worlds in the inner solar system."Although orbit capture is complete, the approach phase will continue for about three weeks. During approach, the Dawn team will continue a search for possible moons around the asteroid; obtain more images for navigation; observe Vesta's physical properties; and obtain calibration data.In addition, navigators will measure the strength of Vesta's gravitational tug on the spacecraft to compute the asteroid's mass with much greater accuracy than has been previously available, according to JPL.Dawn will spend one year orbiting Vesta, then travel to a second destination, the dwarf planet Ceres, arriving in February 2015. The mission to Vesta and Ceres is managed by JPL for the agency's Science Mission Directorate in Washington.Dawn is a project of the directorate's Discovery Program, which is managed by NASA's Marshall Space Flight Center in Huntsville, Alaska.

WASHINGTON, June 7 (Xinhua) -- Advanced hepatitis C patients with chronic liver disease may benefit from drinking coffee during treatment, according to a new study published Tuesday in Gastroenterology, the official journal of the American Gastroenterological Association Institute.The study shows that patients who received peginterferon plus ribavirin treatment and who drank three or more cups of coffee per day were two times more likely to respond to treatment than non- drinkers.Among non-drinkers, 46 percent had an early virologic response; 26 percent had no detectable serum hepatitis C virus (HCV) ribonucleic acid at week 20; 22 percent had no detectable serum at week 48; and 11 percent had a sustained virologic response. In contrast, the corresponding proportions for those who drank three or more cups of coffee per day were 73 percent, 52 percent, 49 percent and 26 percent, respectively."Coffee intake has been associated with a lower level of liver enzymes, reduced progression of chronic liver disease and reduced incidence of liver cancer," said Neal Freedman, of the National Cancer Institute and lead author of this study. "Although we observed an independent association between coffee intake and virologic response to treatment, this association needs replication in other studies."Approximately 70 to 80 percent of individuals exposed to HCV become chronically infected. Worldwide, these individuals are estimated to number between 130 and 170 million. Higher coffee consumption has been associated with slower progression of pre- existing liver disease and lower risk of liver cancer. However, the relationship with response to anti-HCV treatment had not been previously evaluated.